25 May 2021
Acacia Pharma to Participate in Jefferies Virtual Healthcare Conference
Cambridge, UK and Indianapolis, US – 25 May 2021, 07:00 CEST: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a commercial-stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy, announces that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, 1 June 2021 at 08:00 ET (14:00 CEST).
A replay of the presentation will be available on the Jefferies conference website to registered conference attendees for 30 days post the event. Presentation slides will also be made available after the event through the investor section (Financial Reports and Presentations) of the Company’s website, www.acaciapharma.com.